Experimental Fragile X medications may hold promise for autism

07/25/2008 | St. Louis Post-Dispatch

Small trials of drugs meant to treat the underlying Fragile X disorder rather than its symptoms are alleviating behavioral problems and reducing seizures, but have not yet been approved by the FDA for larger trials. Some researchers say such drugs may also be effective for treating children with autism, which is closely tied to Fragile X.

View Full Article in:

St. Louis Post-Dispatch

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Technical Assistance Associate (8156)
American Institutes for Research
Washington, DC
Director, Curriculum & Content
Houghton Mifflin Harcourt
Nashville, TN
Senior Technical Assistance Consultant
American Institutes for Research
Washington, DC
Associate Account Executive
Houghton Mifflin Harcourt
Cheyenne, WY
Technical Assistance Consultant
American Institutes for Research
Washington, DC